Last updated on April 19, 2014 at 7:50 EDT

Latest Roche 454 Sequencing Systems Stories

2012-12-11 08:28:05

PENZBERG, Germany, December 11, 2012 /PRNewswire/ -- - International study presented at American Society of Hematology Meeting demonstrates the potential of 454 Sequencing Systems to comprehensively characterize an individual's blood cancer type to guide personalized therapy decisions At the American Society of Hematology Meeting (ASH) Roche announced today the presentation of results from the large scale study IRON-II through an international research consortium. Based...